PortfoliosLab logo

Cytokinetics, Incorporated

CYTK
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US23282W6057
CUSIP
23282W605

CYTKPrice Chart


Click Calculate to get results
S&P 500

CYTKPerformance

The chart shows the growth of $10,000 invested in Cytokinetics, Incorporated on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $15,563 for a total return of roughly 55.63%. All prices are adjusted for splits and dividends.


CYTK (Cytokinetics, Incorporated)
Benchmark (S&P 500)

CYTKReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M31.11%
6M44.55%
YTD39.75%
1Y21.56%
5Y24.16%
10Y14.16%

CYTKMonthly Returns Heatmap


Click Calculate to get results

CYTKSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Cytokinetics, Incorporated Sharpe ratio is 0.23. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


CYTK (Cytokinetics, Incorporated)
Benchmark (S&P 500)

CYTKDividends


CYTK doesn't pay dividends

CYTKDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CYTK (Cytokinetics, Incorporated)
Benchmark (S&P 500)

CYTKWorst Drawdowns

The table below shows the maximum drawdowns of the Cytokinetics, Incorporated. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Cytokinetics, Incorporated is 85.63%, recorded on Oct 10, 2014. It took 1406 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-85.63%Apr 15, 20101132Oct 10, 20141406May 13, 20202538
-47.31%Jul 16, 202061Oct 9, 2020194Jul 20, 2021255
-17.51%Jan 15, 20109Jan 28, 201052Apr 14, 201061
-10.77%Jul 9, 20203Jul 13, 20201Jul 14, 20204
-9.81%May 19, 202012Jun 4, 20208Jun 16, 202020
-5.51%Jan 12, 20101Jan 12, 20102Jan 14, 20103
-4.38%Jun 23, 20202Jun 24, 20206Jul 2, 20208
-3.52%Jul 23, 20211Jul 23, 2021
-1.93%Jul 6, 20201Jul 6, 20201Jul 7, 20202
-1.71%May 14, 20201May 14, 20201May 15, 20202

CYTKVolatility Chart

Current Cytokinetics, Incorporated volatility is 183.55%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CYTK (Cytokinetics, Incorporated)
Benchmark (S&P 500)

Portfolios with Cytokinetics, Incorporated


Loading data...

More Tools for Cytokinetics, Incorporated